1623 related articles for article (PubMed ID: 35276067)
1. Using ultrasound and angiogenic markers from a 19- to 23-week assessment to inform the subsequent diagnosis of preeclampsia.
Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
Am J Obstet Gynecol; 2022 Aug; 227(2):294.e1-294.e11. PubMed ID: 35276067
[TBL] [Abstract][Full Text] [Related]
2. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes.
Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
Am J Obstet Gynecol; 2021 May; 224(5):518.e1-518.e11. PubMed ID: 33166504
[TBL] [Abstract][Full Text] [Related]
3. The impact of the definition of preeclampsia on disease diagnosis and outcomes: a retrospective cohort study.
Reddy M; Fenn S; Rolnik DL; Mol BW; da Silva Costa F; Wallace EM; Palmer KR
Am J Obstet Gynecol; 2021 Feb; 224(2):217.e1-217.e11. PubMed ID: 32795430
[TBL] [Abstract][Full Text] [Related]
4. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
[TBL] [Abstract][Full Text] [Related]
5. The additive role of angiogenic markers for women with confirmed preeclampsia.
Suresh S; Patel E; Mueller A; Morgan J; Lewandowski WL; Verlohren S; von Dadelszen P; Magee LA; Rana S
Am J Obstet Gynecol; 2023 May; 228(5):573.e1-573.e11. PubMed ID: 36356699
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population.
Chaemsaithong P; Pooh RK; Zheng M; Ma R; Chaiyasit N; Tokunaka M; Shaw SW; Seshadri S; Choolani M; Wataganara T; Yeo GSH; Wright A; Leung WC; Sekizawa A; Hu Y; Naruse K; Saito S; Sahota D; Leung TY; Poon LC
Am J Obstet Gynecol; 2019 Dec; 221(6):650.e1-650.e16. PubMed ID: 31589866
[TBL] [Abstract][Full Text] [Related]
7. Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia.
Reddy M; Palmer K; Rolnik DL; Wallace EM; Mol BW; Da Silva Costa F
Ultrasound Obstet Gynecol; 2022 May; 59(5):596-605. PubMed ID: 34985800
[TBL] [Abstract][Full Text] [Related]
8. Comparison of competing-risks model with angiogenic factors in midgestation screening for preterm growth-related neonatal morbidity.
Papastefanou I; Menenez M; Szczepkowska A; Gungil B; Syngelaki A; Nicolaides KH
Ultrasound Obstet Gynecol; 2024 May; 63(5):613-618. PubMed ID: 38057964
[TBL] [Abstract][Full Text] [Related]
9. Competing risks model for prediction of small-for-gestational-age neonates from biophysical markers at 19 to 24 weeks' gestation.
Papastefanou I; Nowacka U; Syngelaki A; Mansukhani T; Karamanis G; Wright D; Nicolaides KH
Am J Obstet Gynecol; 2021 Nov; 225(5):530.e1-530.e19. PubMed ID: 33901487
[TBL] [Abstract][Full Text] [Related]
10. Preterm and term pre-eclampsia: Relative burdens of maternal and perinatal complications.
von Dadelszen P; Syngelaki A; Akolekar R; Magee LA; Nicolaides KH
BJOG; 2023 Apr; 130(5):524-530. PubMed ID: 36562190
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic utility of serial circulating placental growth factor levels and uterine artery Doppler waveforms in diagnosing underlying placental diseases in pregnancies at high risk of placental dysfunction.
Agrawal S; Parks WT; Zeng HD; Ravichandran A; Ashwal E; Windrim RC; Hobson SR; Melamed N; Kingdom JC
Am J Obstet Gynecol; 2022 Oct; 227(4):618.e1-618.e16. PubMed ID: 35644246
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of angiogenic factors in prediction of growth-related neonatal morbidity at term and comparison with competing-risks model.
Papastefanou I; Nobile Recalde A; Silva Souza Y; Syngelaki A; Nicolaides KH
Ultrasound Obstet Gynecol; 2024 Apr; 63(4):457-465. PubMed ID: 37963283
[TBL] [Abstract][Full Text] [Related]
13. The implications of the Fetal Medicine Foundation 35- to 36-week preeclampsia prediction competing-risk model on timing of birth.
von Dadelszen P; Syngelaki A; Wright A; Akolekar R; Magee LA; Wright D; Nicolaides KH
Am J Obstet Gynecol; 2023 Apr; 228(4):457.e1-457.e7. PubMed ID: 36206987
[TBL] [Abstract][Full Text] [Related]
14. Routine assessment of cerebroplacental ratio at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
Akolekar R; Ciobanu A; Zingler E; Syngelaki A; Nicolaides KH
Am J Obstet Gynecol; 2019 Jul; 221(1):65.e1-65.e18. PubMed ID: 30878322
[TBL] [Abstract][Full Text] [Related]
15. Incidence of small-for-gestational-age infant birthweight following early intertwin fetal growth discordance in dichorionic and monochorionic twin pregnancies.
Reforma LG; Febres-Cordero D; Trochtenberg A; Modest AM; Collier AY; Spiel MH
Am J Obstet Gynecol; 2022 May; 226(5):726.e1-726.e9. PubMed ID: 34838799
[TBL] [Abstract][Full Text] [Related]
16. T2*-weighted placental magnetic resonance imaging: a biomarker of placental dysfunction in small-for-gestational-age pregnancies.
Hansen DN; Sinding M; Petersen A; Christiansen OB; Uldbjerg N; Peters DA; Frøkjær JB; Sørensen A
Am J Obstet Gynecol MFM; 2022 May; 4(3):100578. PubMed ID: 35114424
[TBL] [Abstract][Full Text] [Related]
17. Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension.
Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
Am J Obstet Gynecol; 2021 Sep; 225(3):305.e1-305.e14. PubMed ID: 33812812
[TBL] [Abstract][Full Text] [Related]
18. Prenatal prediction of adverse outcome using different charts and definitions of fetal growth restriction.
Mascherpa M; Pegoire C; Meroni A; Minopoli M; Thilaganathan B; Frick A; Bhide A
Ultrasound Obstet Gynecol; 2024 May; 63(5):605-612. PubMed ID: 38145554
[TBL] [Abstract][Full Text] [Related]
19. Two-stage approach for prediction of small-for-gestational-age neonate and adverse perinatal outcome by routine ultrasound examination at 35-37 weeks' gestation.
Akolekar R; Panaitescu AM; Ciobanu A; Syngelaki A; Nicolaides KH
Ultrasound Obstet Gynecol; 2019 Oct; 54(4):484-491. PubMed ID: 31271475
[TBL] [Abstract][Full Text] [Related]
20. Fetal growth restriction and small for gestational age as predictors of neonatal morbidity: which growth nomogram to use?
Leon-Martinez D; Lundsberg LS; Culhane J; Zhang J; Son M; Reddy UM
Am J Obstet Gynecol; 2023 Dec; 229(6):678.e1-678.e16. PubMed ID: 37348779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
